@ShahidNShah
Telemedicine Platform Offers Outpatient COVID-19 Treatment
Alpha Medical, a virtual primary care group that empowers women to take control of their healthcare by offering a medical team specifically trained for a woman’s unique needs, announces it will prescribe PAXLOVID, an investigational medication used to treat mild-to-moderate COVID-19 in adults and children 12 years of age and older, and are at high risk for progression to severe COVID-19, including hospitalization or death, under a EUA. Since Alpha offers continuity of care through dedicated providers that patients can return to with every visit, their personalized treatment plan can also take into account potential drug interactions and other pre-existing conditions that may affect their eligibility for PAXLOVID.
Continue reading at hitconsultant.net
Make faster decisions with community advice
- Behavioral health and telemedicine: What's in store for 2022
- Critical Medical Device Risks Continue to Threaten Hospital Security & Patient Safety
- Nurse Burnout Even Bigger Challenge Than Physician Burnout
- CIOs' 5-year plans for precision medicine and emerging technologies
- Clamping Down on Upcoding Risk: 3 Steps to Ensure Proper Payment & Compliance
Next Article
-
CIOs' 5-year plans for precision medicine and emerging technologies
One of the next big shifts in patient care will be precision medicine will be "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, …
Posted Jan 25, 2022 Genomics & Precision Medicine